Alpha 2.0
Login Register
» Articles » PMID: 26251093

Neprilysin: Biotarget and Biomarker in Heart Failure

Overview
Journal JACC Heart Fail
Publisher Elsevier
Date 2015 Aug 8
PMID 26251093
Citations 4
Authors
Marie-France Seronde
Alexandre Mebazaa
Affiliations
Soon will be listed here.
Citing Articles

Soluble Neprilysin　- Cardiac Function and Outcome in Hypertrophic Cardiomyopathy.

Yoshihisa A, Yokokawa T, Ichijo Y, Kimishima Y, Kanno Y, Misaka T Circ Rep. 2021; 1(6):261-267.

PMID: 33693148 PMC: 7889477. DOI: 10.1253/circrep.CR-19-0034.

Soluble neprilysin and long-term clinical outcomes in patients with coronary artery disease undergoing percutaneous coronary intervention: a retrospective cohort study.

Choi I, Lim S, Hwang Y, Lee D, Lee W, Lee K BMC Cardiovasc Disord. 2020; 20(1):360.

PMID: 32762650 PMC: 7409669. DOI: 10.1186/s12872-020-01636-5.

Natriuretic peptide family as diagnostic/prognostic biomarker and treatment modality in management of adult and geriatric patients with heart failure: remaining issues and challenges.

Zhang Z, Li R, Yang F, Xi L J Geriatr Cardiol. 2018; 15(8):540-546.

PMID: 30344534 PMC: 6188938. DOI: 10.11909/j.issn.1671-5411.2018.08.008.

Management of suspected acute heart failure dyspnea in the emergency department: results from the French prospective multicenter DeFSSICA survey.

Chouihed T, Manzo-Silberman S, Peschanski N, Charpentier S, Elbaz M, Savary D Scand J Trauma Resusc Emerg Med. 2016; 24(1):112.

PMID: 27639971 PMC: 5026775. DOI: 10.1186/s13049-016-0300-x.